This is unpublished


The program has been developed to train gynecologic oncologists who will be leaders in patient care, research, surgical expertise, innovative cancer therapies, and education. We intend to accomplish this by training fellows in the comprehensive management of gynecologic malignancies and research. We believe that strong mentorship is the best way to assure success of our fellows and therefore we will pair them with both research and clinical mentors.

The fellowship is based primarily at the University of Washington Medical Center (UWMC) and Fred Hutchinson Cancer Center (FHCC), and includes rotations at both the UWMC Montlake and UWMC Northwest campuses. UWMC Montlake is a 570-bed hospital providing tertiary care for the Pacific Northwest region. It is a major clinical resource for high-risk obstetrics, neonatology, gynecologic oncology, urogynecology, assisted reproductive endocrinology, infectious diseases, genetics, and breast cancer. UWMC Northwest is a 281-bed hospital, and provides additional opportunity for training in minimally invasive surgery and outpatient management.

The SCCA Fred Hutchinson Cancer Center provides comprehensive cancer care for the Northwest region and is in an alliance between UWMC Children's Hospital and Regional Medical Center (CHMC). FHCRC and UWMC are designated as an NCI Comprehensive Cancer Center. As part of this consortium, there is a dedicated gynecologic cancer research program.

The division of gynecologic oncology at UW includes eleven board-certified gynecologic oncologists. Each faculty member is active in clinical and/or laboratory research. While the surgical and clinical experience is exceptional, this program also provides an excellent opportunity for epidemiologic or basic science research. FHCC has developed a gynecologic cancer research program (GCRP) that brings together researchers with common interests in gynecologic malignancies, provides infrastructure for data collection, tissue banking, and funds for pilot projects. FHCC, in collaboration with UW, currently has an NIH ovarian cancer SPORE grant, one of only five in the U.S.

Our fellowship, in partnership with the FHCC Medical/Heme Oncology program, is proud to offer fellows two years of research during their fellowship. Fellows may either spend those years on projects focused on basic science or health services research. For fellows with interests in any of these areas, we have identified mentors who have agreed to participate in the research training.

The UW provides office space, computers, and administrative graphics support for the fellows. UW fellows will have access to the Health Science Library resources.

At all times fellows will adhere to an 80-hour work week.

2024 Application Information

Applications will be accepted through the Electronic Residency Application System (ERAS) website:

NOTE: Applicants must be USA citizens or permanent residents (green card) and must have completed an ACGME accredited residency in obstetrics and gynecology by the fellowship start date. Due to the nature of fellowship funding, applications from H1B and J1 Visa holders cannot be accepted.

We are following the Society of Gynecologic Oncology Common Application Dates ( 

2024 Application


April 1, 2024

2024 Fellowship Interview Dates: 

Friday, July 12th & Friday, July 19th

Applications must include

  • Three letters of recommendation, one of which must be from your Residency Program Director
  • Current curriculum vitae
  • Personal statement
  • Official transcript from all medical schools attended
  • MSPE
  • USMLE transcript, including all attempts
  • CREOG scores
  • Copy of medical school diploma


Gynecologic Oncology Fellowship Administrator
Department of Obstetrics and Gynecology, Box 356460
University of Washington School of Medicine
Seattle, WA 98195-6460
Phone: 206-685-9640